A framework for the clinical implementation of optical genome mapping in hematologic malignancies
Brynn Levy(Columbia University Irving Medical Center), Adam C. Smith(Institute for Medical Research), Barbara Dewaele(KU Leuven), Mar Mallo(Josep Carreras Leukaemia Research Institute), Alexander Hoischen(Radboud University Nijmegen), Gordana Raca(Children's Hospital of Los Angeles), Anna Puiggros(Hospital Del Mar), Ravindra Kolhe(St. Jude Children's Research Hospital), Blanca Espinet(Hospital Del Mar), Rashmi Kanagal‐Shamanna(The University of Texas MD Anderson Cancer Center), Marian Stevens‐Kroef(Radboud University Nijmegen), Françesc Solé(Fundación Josep Carreras Contra la Leucemia), Ben Clifford(BioNano Genomics (United States)), Tuomo Mantere(Oulu University Hospital), Katrina Rack(KU Leuven), Kornelia Neveling(University of Würzburg), Daniël Olde Weghuis(Radboud University Nijmegen), Nikhil Sahajpal(Greenwood Genetic Center)
Cited by 49
Related Papers
Chromosomal Microarray versus Karyotyping for Prenatal Diagnosis
|New England Journal of Medicine|2012|1.4k
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
|Nature Genetics|2010|734
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633
Ibrutinib and Venetoclax for First-Line Treatment of CLL
|New England Journal of Medicine|2019|502